CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Drugs.com New Drug Approvals
Original article

FDA Approves Revtorpyk (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

FDA Decision
Related Companies

Read the original article

Published by Drugs.com New Drug Approvals on July 14, 2026 8:07 PM

Read Original